TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Strängnäsvaccin AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
4,306
|
3,456
|
3,524 |
| Financial expenses |
0
|
0
|
1 |
| Earnings before taxes |
139
|
-218
|
-383 |
| EBITDA |
155
|
-81
|
-231 |
| Total assets |
1,142
|
1,227
|
1,678 |
| Current assets |
1,021
|
1,076
|
1,374 |
| Current liabilities |
103
|
96
|
141 |
| Equity capital |
1,029
|
1,127
|
1,531 |
| - share capital |
50
|
50
|
50 |
| Employees (average) |
3
|
0
|
0 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
90.1%
|
91.9%
|
91.2% |
| Turnover per employee | 1,435 | ||
| Profit as a percentage of turnover |
3.2%
|
-6.3%
|
-10.9% |
| Return on assets (ROA) |
12.2%
|
-17.8%
|
-22.8% |
| Current ratio |
991.3%
|
1120.8%
|
974.5% |
| Return on equity (ROE) |
13.5%
|
-19.3%
|
-25.0% |
| Change turnover |
850
|
-68
|
-268 |
| Change turnover % |
25%
|
-2%
|
-7% |
| Chg. No. of employees |
3
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.